Intra-Cellular Therapies Balance Sheet

Financials in millions ZAR. Fiscal year is January - December.

Millions ZAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	10,103	10,959	15,299	8,736	194
Short-Term Investments	18	24	31	31	-
Cash & Short-Term Investments	10,121	10,983	15,330	8,767	194
Cash Growth	-7.85%	-28.36%	74.86%	4419.07%	-
Accounts Receivable	2,871	2,220	3,215	2,982	2,330
Other Receivables	2,341	2,362	1,923	1,384	1,026
Receivables	5,212	4,582	5,138	4,366	3,356
Inventory	3,444	4,011	3,181	2,546	1,149
Prepaid Expenses	-	-	-	-	118
Other Current Assets	-	66	149	695	-
Total Current Assets	18,777	19,642	23,798	16,374	4,817
Property, Plant & Equipment	19,722	19,477	10,656	10,568	8,436
Long-Term Investments	2,458	1,132	798	386	450
Goodwill	-	-	8	8	8
Other Intangible Assets	300	313	74	110	150
Long-Term Accounts Receivable	229	194	1	-	44
Long-Term Deferred Tax Assets	770	471	503	378	-
Other Long-Term Assets	5,821	5,257	4,737	3,461	2,991
Total Assets	48,077	46,486	40,575	31,285	16,896
Accounts Payable	2,696	3,287	2,089	1,713	2,314
Accrued Expenses	3,305	3,576	2,254	1,881	1,834
Current Portion of Long-Term Debt	-	66	60	63	221
Current Portion of Leases	31	34	31	29	24
Current Income Taxes Payable	482	102	25	278	1
Current Unearned Revenue	125	191	23	25	-
Other Current Liabilities	1,559	1,431	867	272	1,303
Total Current Liabilities	8,198	8,687	5,349	4,261	5,697
Long-Term Debt	-	-	-	-	361
Long-Term Leases	19	32	62	92	127
Long-Term Deferred Tax Liabilities	1,567	1,637	1,421	1,400	581
Other Long-Term Liabilities	11,789	11,135	7,179	6,609	5,519
Total Liabilities	21,973	21,890	14,416	12,811	12,740
Common Stock	11,323	11,323	11,323	10,041	-
Additional Paid-In Capital	965	965	965	965	-
Retained Earnings	11,449	9,686	11,453	3,039	-4,894
Treasury Stock	-980	-493	-302	-183	-
Comprehensive Income & Other	2,803	3,128	2,834	2,711	7,655
Total Common Equity	25,560	24,609	26,273	16,573	2,761
Minority Interest	544	-13	-114	1,901	1,395
Shareholders' Equity	26,104	24,596	26,159	18,474	4,156
Total Liabilities & Equity	48,077	46,486	40,575	31,285	16,896
Total Debt	50	132	153	184	733
Net Cash (Debt)	10,071	10,851	15,177	8,583	-539
Net Cash Growth	-7.19%	-28.50%	76.83%	-	-
Net Cash Per Share	74.09	77.62	111.56	81.27	-8.68
Filing Date Shares Outstanding	133.57	136.9	137.55	133.6	62.11
Total Common Shares Outstanding	133.57	136.9	137.55	133.6	62.11
Working Capital	10,579	10,955	18,449	12,113	-880
Book Value Per Share	191.37	179.76	191.01	124.05	44.45
Tangible Book Value	25,260	24,296	26,191	16,455	2,603
Tangible Book Value Per Share	189.12	177.47	190.41	123.17	41.91
Land	2,764	2,703	1,356	1,305	1,315
Machinery	30,894	30,502	26,891	25,577	22,519
Construction In Progress	9,253	7,214	5,369	5,606	5,485

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.